Efficacy of Probiotic Against Functional Constipation
Launched by MIN-TZE LIONG · Nov 2, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a probiotic on people who suffer from functional constipation, which is a condition where individuals have infrequent or difficult bowel movements without an obvious medical cause. The researchers want to see if taking a probiotic can help improve gut health and relieve constipation symptoms in adults aged 18 to 81. Currently, they are looking for participants to join the study.
To be eligible for this trial, you should have been diagnosed with functional constipation based on specific guidelines. However, if you have other types of constipation, such as those caused by certain diseases or medications, or if you are currently taking antibiotics, you won't be able to participate. If you decide to join, you can expect to take the probiotic as part of the study, and there will be follow-up assessments to see how well it works for you. This trial is a great opportunity to contribute to research that could help many people dealing with constipation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Meet the diagnostic criteria for functional constipation in the Rome IV
- • Ruled out for IBS or secondary constipation
- Exclusion Criteria:
- • Diagnosed with refractory constipation
- • Any other constipation caused by neurological diseases, metabolic diseases, obstructive diseases and drugs
- • Mental illness
- • Immunodeficiency diseases or used immunosuppressants, serious diseases of the heart, brain, kidney and other systems, malignant tumors, intestinal perforation, intestinal obstruction, intestinal bleeding
- • Currently using antibiotics or have a history of taking antibiotics in the past 4 weeks.
- • Participating in other clinical trials
About Min Tze Liong
Min-Tze Liong is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on developing novel therapeutics and enhancing patient care, the organization collaborates with a network of leading healthcare professionals and research institutions. Min-Tze Liong is committed to rigorous scientific standards and ethical practices, ensuring the safety and efficacy of treatments through comprehensive trial designs and robust data analysis. By fostering a culture of collaboration and excellence, Min-Tze Liong aims to bring transformative healthcare solutions to market, improving outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Deyang, Sichuan, China
Pulau Pinang, Penang, Malaysia
Patients applied
Trial Officials
Min Liong, PhD
Principal Investigator
Universiti Sains Malaysia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported